# Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room

> **NCT04726592** · PHASE3 · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 323 (actual)

## Conditions studied

- Migraine
- Migraine Without Aura
- Migraine With Aura
- Headache

## Interventions

- **DRUG:** Clorazepate Dipotassium
- **DRUG:** Placebo
- **DRUG:** Ketoprofen
- **DRUG:** Metoclopramide

## Key facts

- **NCT ID:** NCT04726592
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-07-08
- **Primary completion:** 2024-04-10
- **Final completion:** 2024-04-10
- **Target enrollment:** 323 (ACTUAL)
- **Why stopped:** It has been determined that continuing with enrollments in this study is no longer justified due to the lack of significant impact on the expected outcomes.
- **Last updated:** 2025-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04726592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04726592, "Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT04726592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*